DEHYDROEPIANDROSTERONE (DHEA) - ANVISA Registration 80048490102

Access comprehensive regulatory information for DEHYDROEPIANDROSTERONE (DHEA) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80048490102 and manufactured by MONOBIND, INC. The registration is held by USA DIAGNOSTICA LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including LDN LABOR DIAGNOSTIKA NORD GMBH & CO., DRG INSTRUMENTS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80048490102
Registration Details
ANVISA Registration Number: 80048490102
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

DHEA Test System – ELISA
Risk Class II

Registration Details

80048490102

25351413649202413

02330159000108

Company Information

MONOBIND, INC
United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Dec 23, 2024

VIGENTE

09/18/2025 19:00:01